Latest debt-to-equity ratio
ProQR Therapeutics Debt-to-equity ratio
Direct answer
ProQR Therapeutics's debt-to-equity ratio is 19.27%.
The verified market snapshot reports 19.27%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free ProQR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 19.27%
Explore related company data
View ProQR Therapeutics's market capitalizationView ProQR Therapeutics's price-to-book ratioView ProQR Therapeutics's return on equityView ProQR Therapeutics's dividend yieldView ProQR Therapeutics's 52-week price rangeView ProQR Therapeutics's revenue growthView ProQR Therapeutics's profit marginView all ProQR Therapeutics key metricsReturn to ProQR Therapeutics profile